15441-10-8

Usage

Uses

Used in Pharmaceutical Preparations:
3-(Aminosulfonyl)propanoic acid is used as an active pharmaceutical ingredient for the development of various medications. Its sulfonamide group plays a crucial role in the synthesis of sulfa drugs, which are a significant class of antibiotics.
Used in Laboratory Research:
3-(Aminosulfonyl)propanoic acid is employed as a reagent or intermediate in laboratory research, particularly in the fields of organic chemistry and biochemistry. Its unique properties make it a valuable tool for studying chemical reactions and biological processes.
Used in Chemical Syntheses:
3-(Aminosulfonyl)propanoic acid is used as a building block in the synthesis of more complex organic molecules. Its presence in various chemical structures allows for the creation of a wide range of compounds with diverse applications.
Used in Industrial Applications:
This versatile chemical is utilized in various industrial processes, where its strong acidic properties and reactivity contribute to the production of different products. Its presence in the synthesis of various compounds makes it an essential component in the chemical industry.

Upstream product

• 15441-08-4 methyl 3-sulfamoylpropanoate 

Relevant academic research and scientific papers

AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES

The present invention relates to medicine and includes a method for preventing and treating diseases caused by RNA- and DNA-containing viruses, and concomitant diseases, wherein the method comprises the use of an effective amount of compounds of general formula I or pharmaceutically acceptable salts thereof. The invention also relates to methods for preparing said compounds, pharmaceutical compositions for the prevention or treatment of diseases caused by RNA- and DNA-containing viruses, said compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof. The invention addresses the object of providing a novel agent effective in the treatment of diseases caused by an RNA-containing virus belonging to the Enterovirus, Metapneumovirus, Pneumovirus, Respirovirus, or Alfa-coronavirus genus, and/or by a DNA-containing virus belonging to the Adenoviridae and/or Herpesviridae family, and in the prevention and treatment of asthma exacerbation, chronic obstructive pulmonary disease, mucoviscidosis, conjunctivitis, gastroenteritis, hepatitis, myocarditis; in the prevention and treatment of rhinorrhea, acute and infectious rhinitis, pharyngitis, nasopharyngitis, tonsillitis, laryngitis, laryngotracheitis, laryngotracheobronchitis, bronchitis, bronchiolitis, pneumonia, or airway obstructive syndrome.